B.Sc. in Biochemistry and Chemistry, M.Sc. in Nanotechnology, Ph.D. in Molecular Chemical Sciences
Mohamed Sallam works at the intersection of radiotheranostics, imaging, and targeted drug delivery, with a focus on helping promising ideas move closer to clinical use. His work involves developing next generation radiopharmaceutical platforms that bring together CNS targeted delivery, nanobody engineering, and biomarker responsive imaging, always guided by benign-by-design principles and a thoughtful approach to impact. Since October 2024, Mohamed has been a Postdoctoral Research Fellow at the Inflammation Research Centre, VIB Ghent University, where he develops advanced CNS targeted systems that integrate imaging and therapy. Alongside his academic work, he has been involved in business innovation and early stage entrepreneurial activities in Europe, Asia, and Australia, gaining experience in technology translation, start-up ecosystems, and industry collaboration. He is motivated by careful science, practical problem solving, and the belief that meaningful progress often happens quietly, at the intersection of curiosity and responsibility.